Exclusively focused on representing plaintiffs—especially in mass tort litigation—Roopal Luhana prides herself on providing unsurpassed professional legal services in pursuit of the specific goals of her clients and their families.
In 2020, there were more recalls for drugs and medical devices than there were in 2019. This continued the trend that has been going on for years. For example, there were more medical devices recalled in 2019 than in each of the previous four years.…
In June 2020, Janssen Pharmaceuticals changed the warnings on the product label for the U.S. versions of interstitial cystitis (IC) drug Elmiron (pentosan polysulfate sodium or PPS). The new warnings alerted doctors and patients to the potential risk of vision damage. Many American consumers, howeve
In June 2019, online pharmacy Valisure detected a cancer-causing agent (NDMA) in the popular heartburn drug Zantac (ranitidine). Since then, thousands of consumers have been concerned that if they took the drug—particularly if they took it for long periods—they may now be at an increased…
When Bayer announced in July 2018 that it would stop selling the permanent birth control device Essure, the U.S. Food and Drug Administration (FDA) required the company to continue to evaluate long-term safety information in women who received the device. According to the latest analysis…
A Florida man has recently joined the Zantac MDL proceeding in the U.S. District Court for the District of Southern Florida. He filed a short-form complaint alleging that he developed cancer after using Zantac for several years. The U.S. Judicial Panel on Multidistrict Litigation (JPML)…
In June 2020, Janssen Pharmaceuticals, which manufactures the interstitial cystitis (IC) drug Elmiron, updated the warning label on the medication, alerting patients and doctors of the potential risk of vision damage. Unfortunately, there is evidence that suggests that the drug manufacturer knew or
Patients suffering from wet age-related macular degeneration (AMD) who have been treated with the drug Beovu (brolucizumab) may be at an increased risk for another type of vision loss. Though the drug is designed to treat and prevent further vision loss, recent research has suggested…
On September 12, 2019, the FDA first alerted the public to the possible presence of cancer-causing N-nitrosodimethylamine (NDMA) in Zantac and generic ranitidine medications. Since then, drug manufacturers have faced an increasing number of Zantac lawsuits filed against them in courts across the co
On December 15, 2020, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all federally filed Elmiron lawsuits to be consolidated in the District of New Jersey. The Honorable Brian R. Martinotti was appointed to oversee the proceedings. JPML Agrees that Consolidation Is Appropriate fo
If you haven’t heard about the potential cancer risk with Zantac (ranitidine), the popular over-the-counter antacid medication, you’re not alone. Even though the U.S. Food and Drug Administration (FDA) requested the recall of all Zantac and generic ranitidine medications from the market back in Apri
The FDA recently alerted healthcare providers and diabetes patients to another metformin recall. This time, it is Nostrum Laboratories that is recalling four lots of extended-release (ER) metformin (two lots of 500 mg tablets, and two of 750 mg tablets). The company found through testing…
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the recall of all Zantac (ranitidine) antacid products from the market. Many of the products had tested positive for unsafe levels of N-nitroso dimethylamine (NDMA), a cancer-causing substance. Following that recall, many indivi
